Use of an opioid agonist and an opioid antagonist for preparing a Pharmaceutical Form for the treatment of Parkinson's disease and / or at least one symptom of the same.
The present invention provides a pharmaceutical dosage form comprising an opioid agonist and an opioid antagonist for use in the treatment of Parkinson's disease. The present invention also refers to the use of an opioid agonist and an opioid antagonist in such a dosage form.USO DE UN AGONISTA OPIOIDE SELECCIONADO DE UN GRUPO DEFINIDO Y UN ANTAGONISTA OPIOIDE QUE ES NALOXONA, O SALES DE ELLOS, PARA PREPARAR UN MEDICAMENTO ÚTIL PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE PARKINSON, QUE SUFREN DISCINESIA.